Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Open in API
Filings indexed 698 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결(자회사의 주요경영사항)
Regulatory Filings Classification · 80% confidence The document is a regulatory announcement in Korean describing the company’s execution of a single sales and supply contract, including contract amount, counterpart, term, and related details. It does not constitute a financial report (e.g., 10-K, IR), nor does it fit into specific categories like M&A, share issuance, dividend notice, or board changes. Therefore, it falls under the general “Regulatory Filings” fallback category (RNS).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is a detailed quarterly report (“분기보고서”) for the period January 1 to March 31, 2026, containing extensive financial statements, segment disclosures, production and sales data, and notes. It is the actual interim/quarterly report, not merely an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Interim / Quarterly Report Classification · 95% confidence The document is a Korean disclosure of preliminary consolidated financial results for the first quarter of 2026. It includes detailed financial figures such as sales, operating profit, and net income for the current quarter, previous quarter, and year-ago quarter. The document explicitly states that the figures are provisional and prepared under Korean IFRS, and it is a public disclosure (공정공시) of quarterly financial results. The length is about 2394 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. This matches the definition of an Interim / Quarterly Report (IR), which requires actual financial statements or substantive financial data for a period shorter than a full fiscal year. It is not a full Annual Report (10-K), nor is it a simple announcement or certification. Therefore, the correct classification is IR with high confidence. Q1 2026
2026-04-30 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 85% confidence The document is a short notice (‘안내공시’) announcing the scheduled date (2026-04-30) for the publication of the Q1 2026 financial results. It does not contain the results themselves but simply informs investors of the timing of the upcoming report. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or availability of company reports.
2026-04-23 Korean
타인에대한채무보증결정(자회사의 주요경영사항)
Regulatory Filings Classification · 95% confidence The document is a notification regarding a decision to provide a debt guarantee for a third party, specifically for a subsidiary company JVM Europe B.V. It includes details such as the amount guaranteed, the relationship between the company and the debtor, the guarantee period, and relevant financial data of the debtor. The document references a board resolution date and includes compliance with capital market laws. There is no indication that this is a full financial report, audit, or earnings release. Instead, it is a regulatory announcement about a significant corporate action (debt guarantee decision). This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-04-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 96% confidence The document is a Korean “주식등의 대량보유상황보고서(일반)” – a large shareholding status report filed under the Capital Market Act, detailing the number of shares held, changes in holdings, and related contracts. It is not an earnings or annual report, nor a management or legal update, but a regulatory disclosure of major share ownership levels. This matches the definition for Major Shareholding Notification (Code: MRQ).
2026-04-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.